Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a severe and progressive muscle wasting disorder, affecting one in 3500 to 5000 boys worldwide. The NO-sGC-cGMP pathway plays an important role in skeletal muscle function, primarily by improving blood flow and oxygen supply to the muscles during exercise. In fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Shalini Murali, Nordlohne, Johannes, Dietz, Lisa, Vakalopoulos, Alexandros, Haning, Petra, Hartmann, Elke, Seifert, Roland, Hüser, Jörg, Mathar, Ilka, Sandner, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347633/
https://www.ncbi.nlm.nih.gov/pubmed/34360780
http://dx.doi.org/10.3390/ijms22158016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347633/
https://www.ncbi.nlm.nih.gov/pubmed/34360780
http://dx.doi.org/10.3390/ijms22158016

Ejemplares similares